Today's Earnings Calculators Terms of Service Privacy Policy Data Sources Support Mobile app Instagram

StockRay is an AI stock analysis service by Warm Tech Company.

Warm Tech Company | CEO Jinyoung Moon | Reg. 317-27-02126

13, Cheonggyesan-ro 4-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, Korea | partner@warmtech.company

All information provided by Warm Tech Company is for reference only and does not constitute a recommendation to buy or sell any specific stock. You are solely responsible for your investment decisions.

© 2026 Warm Tech Company. All rights reserved.

LENSAR Inc Stock Price·Forecast · AI Analysis | StockRay

LENSAR Inc

LNSR · Healthcare · $85M

$6.90+0.29%

2026 Q2 earnings

Price

$5.84

$6.90

Jul 1, 26Sep 29, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$14M-13.4%

6/'26 vs prev quarter

Company Health

Market Cap$85M

Operating Margin-13.5%

Among 114 Medical - Devices peers

LowMedianHigh

PSR1.4x

median 2.3xPER2.4x

median 24.6x

2026 Q2 EarningsReflected in score

2026 Q1 EarningsReflected in score

2025 Q4 EarningsPreliminary disclosure

2025 Q3 EarningsPreliminary disclosure

2025 Q2 EarningsPreliminary disclosure

Related Stocks

A
Acrivon Therapeutics, Inc. Common Stock
C
CareCloud, Inc.
N
Neonc Technologies Holdings, Inc.
C
Cognition Therapeutics, Inc.
P
Pulmonx Corporation
F
Fractyl Health, Inc.
S
SkinHealth Systems Inc.
T
Telomir Pharmaceuticals, Inc. Common Stock

Daily Prices

09.29$6.90+0.29%

09.28$6.88-0.58%

09.25$6.92-2.26%

09.24$7.08-0.98%

09.23$7.15-1.38%

09.22$7.25+0.55%

09.21$7.21+1.98%

09.18$7.07-0.28%

09.17$7.09+0.14%

09.16$7.08-7.33%

Quarterly Revenue Growth

PriorCurrent

25년 9월25년 12월26년 3월26년 6월26년 9월Est.

Revenue Breakdown

As of Dec 2025

Source: Company IR filings

Product88.9%
Service11.1%

BusinessMedical - Devices·lensar.com↗

“매출이 1분기 1,300만 달러에서 2분기 1,650만 달러로 반등하며 최근 흐름이 다시 살아났고, 전년 동기 대비 18% 성장했어요.”

In the company's words · 2026 2분기 earnings call